Navigation Links
Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
Date:7/22/2008

Cancer Center.

"After years of methodical design and development to optimize our products, these results in end-stage liver cancer patients clearly validate our breakthrough product class. The clinical and mechanistic results were predicted based on extensive lab testing of JX-594. This peer-reviewed publication in Molecular Therapy represents a major clinical and scientific advance for JX-594," said David Kirn, M.D., President & CEO of Jennerex. "As always, we thank the doctors, the patients and their families, and our partners at Green Cross who have all pioneered this treatment with us."

Phase I-II Liver Cancer Study

As previously reported, 14 patients with a variety of treatment-refractory cancer types (e.g. liver, colon, lung) in the liver were treated every three weeks with JX-594 by ultrasound-guided intratumoral injection. Patients had advanced cancers that had failed all available therapies and were therefore considered terminal. Treatment was well-tolerated during dose-escalation up to the maximum-tolerated dose, with the expected mild to moderate flu-like symptoms; no severe toxicities due to treatment were reported up to these doses. Cancer destruction and objective evidence for efficacy were reported in the majority of patients, including all three with primary liver cancer and patients with lung and colon cancers. Tumor responses were achieved in evaluable patients by objective criteria including RECIST (Response Evaluation Criteria in Solid Tumor) (response in 30 percent of patients, stable disease in 60 percent of patients) and Choi criteria (response in 80% of patients). Tumor responses were associated with long-term survival in many patients, including four who survived for 11 to over 18 months. Mechanism-of-action of JX-594 was validated in patients by demonstration of tumor-specific replication and tissue destruction with JX-594, in addition to high-level active expression of the GM-CSF protein in the blood of patients. Thes
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
2. Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
3. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
4. Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma
5. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine
6. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
7. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
8. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
9. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
10. Franklin & Seidelmann Publishes Complex Podiatry MRI Study
11. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014  Diplomat, the nation,s largest independent ... Dreyer to the Board of Directors on September ... will also serve as chair of the Audit Committee. ... of accounting, financial, compliance and operating experience in the ... served as chief financial officer, chief operating officer and ...
(Date:9/19/2014)... Five MinuteClinic walk-in medical clinics are opening inside select CVS/pharmacy stores ... opened in Memphis and Cordova ... in Springfield on September 24 and a ... open October 22.  MinuteClinic is the largest and fastest growing provider ... . The Memphis -area clinics join ...
(Date:9/19/2014)... , September 19, 2014 ... by Equipment Type (Benchtop, Mobile, Industrial, & Laboratory), ... Technology (Tray-style, Manifold, & Rotary) & Geography - ... MarketsandMarkets, defines and segments the lyophilization market on ... with analyses and projections of the market size ...
Breaking Medicine Technology:David Dreyer Appointed to Diplomat Board of Directors 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3
... 2012 , "9 Trends" Report Identifies What,s ... Helping Members Make Healthier Decisions , Using Social Media ... Developing New Ways to Comprehensively Manage Specialty Care , ... Poor health choices add billions in cost to the companies, unions, ...
... Pa. and MAHWAH, N.J., May 17, 2012 Auxilium ... FCB I LLC ("FCB") today announced that the United ... Patent No. 8,178,518 covering, among other things, Testim® 1% ... The newly issued patent, which claims certain pharmaceutical compositions ...
Cached Medicine Technology:Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 2Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 3Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 4Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 5Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim 2Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim 3Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim 4Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim 5
(Date:9/19/2014)... 19, 2014 BearCom, a nationwide ... detailed the key role played by instant, one-to-one ... the healthcare industry. , “In healthcare, speed ... – and in emergency situations, can save precious ... and death,” said Hugh Johnston, Product & Purchasing ...
(Date:9/19/2014)... 9/18/14) A leading Dartmouth researcher, working with The Melanoma ... paper published today in the Journal of the ... the risk of melanoma. , "For the first time, ... of these telomeres play a part in the risk ... Mark Iles, PhD, School of Medicine at the University ...
(Date:9/19/2014)... Your brain structure could help predict how willing you are ... at Yale University found those with greater volume in a ... be more likely to engage in risky behavior than people ... funded by the U.S. National Institute on Aging, involved two ... Northeast. The researchers sought to determine how brain structure influences ...
(Date:9/19/2014)... The Alliance for Bangladesh Worker Safety ... Fire Protection Association (NFPA), a recognized international leader ... a Memorandum of Understanding signed by both organizations, ... stakeholders with information, guidance and access to training ... safety of workers in ready-made garment (RMG) factories ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 In partnership with ... been an active part of the project’s social media efforts. ... which aims to re-define the perception of beauty as it ... began as an idea by Shelly Baer and Vanessa Silberman, ... women as sexy and beautiful. Ginny Dixon, Wendy Crawford, Susan ...
Breaking Medicine News(10 mins):Health News:BearCom Releases Guidelines on Using Two-Way Radios to Improve Communications and Enhance Patient Service in Healthcare 2Health News:BearCom Releases Guidelines on Using Two-Way Radios to Improve Communications and Enhance Patient Service in Healthcare 3Health News:BearCom Releases Guidelines on Using Two-Way Radios to Improve Communications and Enhance Patient Service in Healthcare 4Health News:Melanoma risk found to have genetic determinant 2Health News:Brain Structure Might Help Predict Risky Behavior 2Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 2Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 3Health News:OC Healthcare Agency StudioPMG Partners with The Raw Beauty Project ™ NYC 2014 2
... , DALLAS, Nov. 24 The Baylor Charles ... one of the largest cancer clinical trials cooperative groups in ... Cancer Institute, Southwest Oncology Group conducts clinical trials to prevent ... of life for cancer survivors. , "Joining this prestigious group ...
... , , LAKE SUCCESS, N.Y., Nov. ... ISO certification, an international quality management standard focused ... continually improving business performance. Certification to ISO ... Quality Management System (QMS) has passed a rigorous ...
... ... inflammatory bowel disease is largely unknown, but research will be presented at the upcoming ... Conference, December 3-6 in Hollywood, Florida, that may identify a causative mutation for Crohn’s ... New ...
... , SANTA CLARA, Calif., Nov. 24 ... enterprise mobility, today announced that it was honored in the ... Mobility Router v3.0. Everything Channel,s Tech Innovator Awards celebrate ... throughout the technology channel. , Everything Channel,s Test Center reviewed ...
... , ... company pioneering clinical research of natural remedies, announced today ... want natural solutions for children,s health. A tip ... first in an ongoing "Natural Moms" series, is now ...
... may help ward off peripheral artery disease, researchers ... people aged 75 and older, the herbal supplement Ginkgo ... a new study finds. , There is some evidence ... leg-circulation problem known as peripheral artery disease, however. , ...
Cached Medicine News:Health News:Baylor Sammons Cancer Center Joins One of Nation's Largest Cancer Clinical Trials Groups 2Health News:Baylor Sammons Cancer Center Joins One of Nation's Largest Cancer Clinical Trials Groups 3Health News:IPRO Earns Third Consecutive Quality Management Certification 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 3Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 4Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 2Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 3Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 4Health News:Bionorica Offers Expert Resources, Health Tips for 'Natural Moms' 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: